Will he stay or will he go? AstraZeneca's shares jump, Teva's sink on report that Soriot will stay put
admin 14th July 2017 Uncategorised 0It’s been a long three days for Teva and AstraZeneca, both of which have faced myriad questions and significant stock moves since a midweek report that AZ chief exec Pascal Soriot had signed on as the new CEO of Teva. Friday, though, Bloomberg’s U.S. Health Team Leader, Drew Armstrong, tweeted out that Soriot had different plans.
More: Will he stay or will he go? AstraZeneca's shares jump, Teva's sink on report that Soriot will stay put
Source: fierce